Medicaid Outlines Plan To Help Pay For Pricey Sickle Cell Gene Therapies

The Centers for Medicare and Medicaid Services will pursue so-called outcomes-based agreements that would put discounts or rebates in place on two new expensive gene therapies if they don't deliver promised results for patients with sickle cell disease.

Related Keywords

Texas ,United States ,Santa Clara County ,California ,Georgia ,Louisiana ,Alabama ,Mississippi ,Maryland ,Californians ,Santa Clara ,Suzanne Crouch ,Civil Medicaid Fraud Division ,Centers For Medicare ,Medicaid Services ,Developmental Disabilities Task ,Maryland Department Of Health ,Services Agency In Gilroy ,Services Administration ,Social Services Agency ,Maryland Department ,Social Services Administration ,Developmental Disabilities Task Force ,Attendant Care ,Legally Responsible Individuals ,